RMAM
IMGN

Raab & Moskowitz Asset Management’s Immunogen Inc IMGN Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-433
Closed -$2K – 540
2019
Q4 		$2K Buy
+433
New +$1.47K ﹤0.01% 507
2018
Q4 		– Sell
-532
Closed -$5K – 528
2018
Q3 		$5K Buy
+532
New +$5.11K ﹤0.01% 461

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Raab & Moskowitz Asset Management's IMGN Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 433 shares — an estimated $2K sold.

Raab & Moskowitz Asset Management first reported a position in IMGN in Q3 2018 and held it in 2 quarters. The position peaked at $5K in Q3 2018. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

  • Raab & Moskowitz Asset Management reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
  • Raab & Moskowitz Asset Management sold 433 Immunogen Inc shares in Q1 2020, an estimated $2K.
  • Raab & Moskowitz Asset Management first reported a position in Immunogen Inc in Q3 2018 and held it in 2 quarters.
  • Raab & Moskowitz Asset Management's Immunogen Inc position peaked at $5K in Q3 2018.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.